Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riccardo Sarzani

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 22, 2013
The clinical significance of metabolic syndrome in hypertension: metabolic syndrome increases cardiovascular risk : the contrary positionRiccardo Sarzani
ESC Heart Failure|September 22, 2020
Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trialsFrancesco Spannella, Federico Giulietti, Andrea Filipponi, et al.
Journal of Hypertension|April 10, 2008
Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humansRiccardo Sarzani, Fabio Salvi, Paolo Dessì-Fulgheri, et al.
Advances in Therapy|April 7, 2019
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded "Double-Trouble" Lipid Profile in Overweight/ObeseFrancesco Spannella, Federico Giulietti, Chiara Di Pentima, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 8, 2020
Sodium-glucose co-transporter-2 inhibitors: peculiar "hybrid" diuretics that protect from target organ damage and cardiovascular eventsRiccardo Sarzani, Federico Giulietti, Chiara Di Pentima, et al.
Therapeutic Advances in Chronic Disease|June 30, 2022
Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patientRiccardo Sarzani, Giorgia Laureti, Alessandro Gezzi, et al.
European Heart Journal. Case Reports|February 24, 2025
Pregnancy 3 months after inclisiran injection: a unique case report including newborn baby monitoringMassimiliano Allevi, Matteo Landolfo, Federico Giulietti, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 9, 2020
Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injuryRiccardo Sarzani, Federico Giulietti, Chiara Di Pentima, et al.
Scientific Reports|December 18, 2019
Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-AnalysisFrancesco Spannella, Federico Giulietti, Marica Bordicchia, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 14, 2014
Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factorsRiccardo Sarzani, Marica Bordicchia, Francesco Spannella, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 22, 2013
The clinical significance of metabolic syndrome in hypertension: metabolic syndrome increases cardiovascular risk : the contrary positionRiccardo Sarzani
ESC Heart Failure|September 22, 2020
Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trialsFrancesco Spannella, Federico Giulietti, Andrea Filipponi, et al.
Journal of Hypertension|April 10, 2008
Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humansRiccardo Sarzani, Fabio Salvi, Paolo Dessì-Fulgheri, et al.
Advances in Therapy|April 7, 2019
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded "Double-Trouble" Lipid Profile in Overweight/ObeseFrancesco Spannella, Federico Giulietti, Chiara Di Pentima, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 8, 2020
Sodium-glucose co-transporter-2 inhibitors: peculiar "hybrid" diuretics that protect from target organ damage and cardiovascular eventsRiccardo Sarzani, Federico Giulietti, Chiara Di Pentima, et al.
Therapeutic Advances in Chronic Disease|June 30, 2022
Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patientRiccardo Sarzani, Giorgia Laureti, Alessandro Gezzi, et al.
European Heart Journal. Case Reports|February 24, 2025
Pregnancy 3 months after inclisiran injection: a unique case report including newborn baby monitoringMassimiliano Allevi, Matteo Landolfo, Federico Giulietti, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 9, 2020
Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injuryRiccardo Sarzani, Federico Giulietti, Chiara Di Pentima, et al.
Scientific Reports|December 18, 2019
Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-AnalysisFrancesco Spannella, Federico Giulietti, Marica Bordicchia, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 14, 2014
Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factorsRiccardo Sarzani, Marica Bordicchia, Francesco Spannella, et al.
Pageof 12